as 05-10-2024 4:00pm EST
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | BOCA RATON |
Market Cap: | 21.7M | IPO Year: | N/A |
Target Price: | $5.00 | AVG Volume (30 days): | 23.2K |
Analyst Decision: | Hold | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.68 | EPS Growth: | N/A |
52 Week Low/High: | $1.84 - $4.72 | Next Earning Date: | 05-10-2024 |
Revenue: | $1,199,000 | Revenue Growth: | -98.28% |
Revenue Growth (this year): | 605.07% | Revenue Growth (next year): | 1.11% |
TXMD Breaking Stock News: Dive into TXMD Ticker-Specific Updates for Smart Investing
Associated Press Finance
a day ago
Business Wire
a day ago
Business Wire
a month ago
Insider Monkey
2 months ago
GlobeNewswire
3 months ago
GlobeNewswire
3 months ago
Insider Monkey
3 months ago
Business Wire
3 months ago